Obesity as a medical condition
Over the last 18 months, obesity has been medically defined with a formal recognition as a chronic, medical condition. Obesity needs to enjoy the same employer support you would provide for Mental Health, diabetes, MSK or cardio issues.
A benefit that is needed, now.
Over 2.3m UK adults are currently using GLP-1 drugs, with a further 3.3m considering starting a course in the next 12 months. It is highly likely that GLP-1 provision will be impacting up to 20% of your workforce
- The choice is not whether they will use GLP-1, it’s who they procure this from.
- More unregulated providers are entering the UK market.
- Coaching and support delivers up to 21% more effective weight-loss – the choice of provider makes a huge difference.
Making the right GLP-1 provider choice
The NHS simply cannot cope with the demand for GLP-1 drugs, with less than 6% of eligible individuals receiving treatment via the NHS. Almost all of your employees will be searching the internet for their GLP-1 provision, which comes with a lot of uncertainty
.svg){kind=small}
Provenance of illegal and fake drugs
Unregulated providers
Lack of clinical support to deal with side effects.
Over 13,000 websites to make the right choice from
